(Q51698791)

English

Biomarker-led adaptive trial blazes a trail in breast cancer.

scientific article published in May 2010

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20458285

retrieved

10 April 2018

reference URL

http://europepmc.org/abstract/MED/20458285

title

Biomarker-led adaptive trial blazes a trail in breast cancer. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20458285

retrieved

10 April 2018

reference URL

http://europepmc.org/abstract/MED/20458285

1 reference

Malorye Allison

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20458285

retrieved

10 April 2018

reference URL

http://europepmc.org/abstract/MED/20458285

publication date

1 May 2010

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20458285

retrieved

10 April 2018

reference URL

http://europepmc.org/abstract/MED/20458285

published in

Nature Biotechnology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20458285

retrieved

10 April 2018

reference URL

http://europepmc.org/abstract/MED/20458285

volume

28

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20458285

retrieved

10 April 2018

reference URL

http://europepmc.org/abstract/MED/20458285

issue

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20458285

retrieved

10 April 2018

reference URL

http://europepmc.org/abstract/MED/20458285

page(s)

383-384

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20458285

retrieved

10 April 2018

reference URL

http://europepmc.org/abstract/MED/20458285

cites work

Clinical application of the 70-gene profile: the MINDACT trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNBT0510-383

retrieved

21 January 2018

A gene-expression signature as a predictor of survival in breast cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNBT0510-383

retrieved

21 January 2018

Bayesian clinical trials at the University of Texas M. D. Anderson Cancer Center

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNBT0510-383

retrieved

21 January 2018

Bayesian clinical trials: no more excuses.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNBT0510-383

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0510-383

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1038/NBT0510-383

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20458285

retrieved

10 April 2018

reference URL

http://europepmc.org/abstract/MED/20458285

Dimensions Publication ID

1030819121

0 references

PubMed publication ID

20458285

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20458285

retrieved

10 April 2018

reference URL

http://europepmc.org/abstract/MED/20458285

(Q51698791)

Biomarker-led adaptive trial blazes a trail in breast cancer.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)